97. Ulcerative colitis Clinical trials / Disease details


Clinical trials : 2,527 Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-JapicCTI-194721
01/6/201917/04/2019A Phase I Study of RO7021610 in Patients with Ulcerative ColitisA Phase I Multiple-Dose Study of RO7021610 in Japanese Patients with Ulcerative Colitis Ulcerative colitisIntervention name : RO7021610
INN of the intervention : Efmarodocokin alfa
Dosage And administration of the intervention : RO7021610 will be administrated repeatedly by IV.
Control intervention name : Placebo
INN of the control intervention : -
Dosage And administration of the control intervention : Placebo will be administrated repeatedly by IV.
Chugai Pharmaceutical Co., Ltd.NULLcomplete1880BOTH24Phase 1Japan